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Abstract
Background: Ascariasis and HIV/AIDS are often co-endemic under conditions of poverty in South
Africa; and discordant immune responses to the respective infections could theoretically be
affecting the epidemic of HIV/AIDS in various ways. It is well-known that sensitisation to helminthic
antigens can aggravate or ameliorate several non-helminthic diseases and impair immunisation
against cholera, tetanus and tuberculosis. The human genotype can influence immune responses to
Ascaris strongly. With these factors in mind, we have started to document the extent of long-term
exposure to Ascaris and other helminths in a community where HIV/AIDS is highly prevalent. In
more advanced studies, objectives are to analyse relevant immunological variables (e.g. cytokine
activity and immunoglobulin levels). We postulate that when Ascaris is hyperendemic, analysis of
possible consequences of co-infection by HIV cannot be based primarily on excretion vs non-
excretion of eggs.
Methods: Recall of worms seen in faeces was documented in relation to the age of adult
volunteers who were either seropositive (n = 170) or seronegative (n = 65) for HIV. Reasons for
HIV testing, deworming treatments used or not used, date and place of birth, and duration of
residence in Cape Town, were recorded. Confidence intervals were calculated both for group
percentages and the inter-group differences, and were used to make statistical comparisons.
Results: In both groups, more than 70% of participants were aware of having passed worms, often
both when a child and as an adult. Most of the descriptions fitted Ascaris. Evidence for significantly
prolonged exposure to helminthic infection in HIV-positives was supported by more recall of
deworming treatment in this group (p < 0.05). Over 90% of the participants had moved to the city
from rural areas.
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BMC Infectious Diseases 2006, 6:88 http://www.biomedcentral.com/1471-2334/6/88Conclusion: There was a long-term history of ascariasis (and probably other helminthic
infections) in both of the groups that were studied. In women in the same community, and in
children living where housing and sanitation are better, Ascaris sero-prevalence exceeded egg-
prevalence by two- and three-fold, respectively. For ongoing and future analyses of possible
consequences of co-infection by Ascaris (and/or other helminths) and HIV/AIDS (and/or other
bystander conditions), comparisons must be based mainly on disease-related immunological
variables. Especially in adults, comparisons cannot be based only on the presence or absence of eggs
in excreta.
Background
Some literature reviews and research studies have sug-
gested that immunological responses to frequent chal-
lenge from helminth parasites and other pathogens may
be influencing rates of infection by HIV and/or progres-
sion to AIDS in developing countries [1,2]. Furthermore,
it is likely that the efficacy of anti-HIV vaccines will be
impaired under these conditions [3-5]. Helminthiasis is
usually characterised by a strong type 2 immune profile
[6-8], which can down-regulate an anti-viral type 1 reac-
tion; and a study has shown that a balanced type 1/type 2
response was significantly related to long-term non-pro-
gression of HIV infection [9]. When the maternal immune
profile has been imbalanced by helminthic infection, the
risk of transmitting HIV to babies appears to increase [10].
Theories about immunological relationships between
infection by worms and HIV/AIDS are supported by the
reality of this kind of interaction between helminthiasis
and immune-mediated disease associated with the
human T cell lymphotropic virus type 1 (HTLV-1), which
like HIV is a retrovirus [11].
In many South African communities, high population
densities, poor living conditions and deficient public
health service delivery support ongoing challenge from
various infections, with Ascaris and HIV as components of
the milieu [1,12-19]. The prevailing environmental condi-
tions promote involuntary ingestion of Ascaris eggs, which
either leads to re-infection (the lifespan of Ascaris is rela-
tively short compared to that of other common helminths
[20]) or ensures ongoing antigenic challenge. Most
human adults are probably in a state of immunological
holoendemic equilibrium [21] that reduces patent infec-
tion by Ascaris. In children, infection by Ascaris has been
shown to polarise the immune profile towards type 2,
which is associated with an impaired response to a chol-
era vaccine [22,23]. These Ascaris-specific effects were
reversed by deworming with albendazole [24], which
might be an inexpensive way to improve the efficacy of
potential vaccines against HIV [1-3] and other diseases
[1,4,23-25].
In view of widespread co-endemicity of Ascaris and HIV/
AIDS in South Africa, our first objective is to begin to
define the lifespan history of infection challenge from
Ascaris in people living in communities where HIV/AIDS
is a growing problem. If lifelong challenge is generally
present, further research would aim to ascertain which
immunological and/or genetic variables are better than
the temporary presence or absence of Ascaris eggs in fae-
ces, for assessing the potential for disease interaction. We
are aware of more than 20 recent studies that have used
faecal helminth egg-positivity or egg-negativity as the
main or only worm-related variable in comparisons relat-
ing to HIV infection (and/or other bystander diseases) in
areas where helminths are highly endemic. We contend
that this approach is fundamentally flawed for reasons
that will be discussed. Understanding would improve if
analysis were to be based on variables that include specific
immunoglobulins [6,8,26-28], cytokine ratios [6-9,29-
33], eosinophilia [6,8,13] and genetic markers [34-37]. If
significant disease interaction can be confirmed by the use
of more reliable variables, the overall objective is to then
make recommendations on how implementation of pre-
vention and control of ascariasis and other helminthic
infections might influence the epidemic of HIV/AIDS
[1,2], anti-HIV vaccine testing and the efficacy of immuni-
sation (if vaccines can be produced) [1-3,5].
The present study is based mainly on people who have
moved from rural districts in the Eastern Cape province
(EC) to a suburb of Cape Town (CT). HIV/AIDS is a major
epidemic in both of these environments [17-19]. The only
way to get the history of infestation by worms in the rural
areas from which the people came, was by personal recall
of helminths seen in faeces. This is a reasonable approach
because Ascaris is so large [20], and is especially conspicu-
ous when availability of toilets is limited, as in some
densely-populated rural areas and urban slums
[12,14,15]. The frequency of recall of probable Taenia seg-
ments has also been documented but discussion is
restricted mainly to Ascaris. However, taeniasis and cyst-
icercosis (including neurocysticercosis) are well-known in
both areas [38,39]. Since participation in the study was
voluntary and no deliberate selection was imposed, it is
probable that the participants were representative of most
adults, especially women, living under similar circum-
stances. In the CT community, recent surveys found thatPage 2 of 8
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tal clinics were infected by HIV [17]; and more than 75%
of pupils at 12 primary schools had Ascaris eggs in their
faeces [12]. Stigma (and fear) associated with a positive
HIV test is a major problem that affects the design of
research in communities where the prevalence of HIV/
AIDS is high [40]. Consequently, pragmatic, non-random,
exploratory projects, such as the one now reported, are
sometimes the only way to start research.
Methods
This report covers the first set of results from a project that
was approved by the Ethics Committees of the South Afri-
can Medical Research Council and the University of Stel-
lenbosch, South Africa, under the overall title: Tracking the
immune profile of adults who are either HIV-positive or HIV-
negative, during helminthic infection and anthelmintic treat-
ment.
An HIV/AIDS support group in the CT suburb of Khayelit-
sha was approached about participation in an initial sur-
vey. Information sessions to explain the objectives of the
research and to answer questions, were run by AIDS coun-
sellors serving the support group. After comprehensive
discussion in the vernacular language (isiXhosa), 170
HIV-positive and 65 HIV-negative adults volunteered to
participate and signed informed consent forms. These
documents and completed questionnaires are on file with
the Helminth Section of the Nutritional Intervention
Research Unit, Medical Research Council, CT, South
Africa. The consent given included permission to confirm
HIV status by re-testing.
Retrospective, enquiry-based research was the only way to
obtain lifespan information on the history of infection by
worms (starting in childhood) in the adult volunteers, as
well as demographic details defining the extent of reloca-
tion to CT and the memory of anthelmintic treatment or
non-treatment. A semi-structured questionnaire was
drafted in English, translated into Xhosa, and back-trans-
lated into English to confirm that meanings were con-
veyed accurately. It was tested by Xhosa-speakers for logic,
accuracy and fluency. Adjustments were made as required.
Xhosa-speaking AIDS counsellors interviewed individual
volunteers and recorded their answers to the final ques-
tions. Replies regarding infection by worms were used to
ascertain: (a) if the participant was aware of ever having
passed worms in any way (particularly in faeces), as a
child and/or as an adult; (b) the estimated age when
worms were noticed as a child and/or as an adult; and (c)
the appearance of worms seen, as well as the kind of con-
ventional or traditional medicine that was used for treat-
ment, if any. Date and place of birth were confirmed from
identity documents and used to determine age. Informa-
tion on length of residence in the Khayelitsha suburb of
CT was also obtained.
Wilson's direct method was used to set 95% confidence
intervals (CI) for the percentages shown in the tabulated
results [41]. Differences between percentages for HIV-pos-
itives and HIV-negatives were assessed for significance by
calculating the 95% CI for the net value by Newcombe's
method [41]. When this CI excludes zero, it indicates a
significant difference (p < 0.05). Ages and duration of res-
idence in CT were compared by means of heterosedastic
two-sided t-tests, assuming unequal variance.
Results
HIV/AIDS status
The original motivations for HIV testing are summarised
in Table 1. More than 40% of the HIV-positive group were
tested because they had a clinical condition that can be
AIDS-associated, whereas more than 75% of the HIV-neg-
ative group had volunteered for testing on the basis that
they preferred to know their status.
Demography
The percentage distributions by place of birth, with 95%
confidence intervals, are shown in Table 2. The HIV-posi-
tive volunteers consisted of 143 women and 27 men (n =
Table 1: Original reasons for HIV testing
HIV-positive (n = 170) Numbers Percentage and 95% CI
Possible AIDS-associated condition 72/170 42.3 (36.3, 48.7)
Prevention of mother-to-child transmission 62/170 36.5 (29.6, 43.9)
High-risk behaviour, counselled to test 36/170 21.2 (15.7, 27.9)
HIV-negative (n = 65)
Possible AIDS-associated condition 9/65 13.9 (7.5, 24.3)
A condition not usually AIDS-associated 6/65 9.2 (4.3, 18.7)
Prevention of mother-to-child transmission 1/65 1.5 (0.3, 8.2)
Voluntary testing 49/65 75.4 (63.7, 84.2)
CI = confidence interval.Page 3 of 8
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comprised 52 women and 13 men (n = 65), i.e. 80.0%
women. More than 91% of the HIV-positives and more
than 95% of the HIV-negatives were not born in CT but all
the participants were South Africans.
Age when questioned, duration of residence in CT and 
worm infection as children and adults
The adults in the HIV-positive group were younger than
those in the HIV-negative group and had lived in CT for a
shorter period (p < 0.01, Table 3). For individuals who
were not born in CT (> 91%), the data indicate that worm
infection as a child occurred mainly before relocation to
the city; and as an adult, was after the move. This deduc-
tion is supported by the close concordance of the within-
group means and medians for the estimated ages at which
participants remembered passing worms when children
or adults, respectively. There was no significant difference
between the groups in mean age at the time of childhood
or adult infection. The data suggest that the HIV-positive
adults may have seen worms more recently than the HIV-
negative adults.
Recall of worm infestation
More than 70% of participants in both of the groups were
aware that they had been infected by worms as a child
and/or as an adult (Table 4). A significantly greater per-
centage of HIV-positives remembered having had worms
both when they were children and adults (p < 0.05),
which may indicate more sequential ascariasis (and prob-
ably other helminthic infections) in this group.
Probable identity of worms seen
Relatively reliable identification of helminths in faeces
would pertain to Ascaris because the worms are big, con-
spicuous and sometimes numerous [20]. Descriptions
that combined "long" or "big" with "white", "whitish"
and "pointed" were interpreted as referring to Ascaris,
which is highly prevalent in CT and the Western Cape
province (WC) [12-14], as well as in the EC [15]. Taenia
Table 2: Place of birth of volunteers
HIV-positives (n = 170)2 HIV-negatives (n = 65)2
Place of Birth Numbers % 95% CI Numbers % 95% CI
City of Cape Town 15/170 8.8 5.4, 14.0 3/65 4.6 1.6, 12.7
Western Cape province1 1/170 0.6 0.1, 3.3 0/65 0 0.0, 5.6
Eastern Cape province 151/170 88.8 83.2, 92.7 61/65 93.9 85.2, 97.6
Northern Cape province 1/170 0.6 0.1, 3.3 0/65 0 0.0, 5.6
Gauteng province 1/170 0.6 0.1, 3.3 1/65 1.5 0.3, 8.2
Mpumalanga province 1/170 0.6 0.1, 3.3 0/65 0 0.0, 5.6
CI = confidence interval.
1Excluding the city of Cape Town.
2There were no statistically significant differences between the percentages of HIV-positives and HIV-negatives by place of birth.
Table 3: Age when questioned, duration of residence in Cape Town and worm infection at estimated child and adult ages
HIV-positive (n = 169)1 Age when questioned Duration2 Worms at child age3 Worms at adult age4
Mean age 30.6* 9.5† 9.2 NSD 26.6 NSD
Median age 28.7 8.1 9.0 28.0
Age range 16.4 – 63.1 0.1 – 40.6 4.0 – 14.0 15.0 – 42.0
HIV-negative (n = 63)1 Age when questioned Duration2 Worms at child age3 Worms at adult age4
Mean age 39.9* 13.5† 10.3 NSD 28.9 NSD
Median age 41.6 12.5 10.5 25.0
Age range 15.2 – 74.5 0.1 – 54.1 5.0 – 14.0 15.0 – 49.0
1Numbers reduce from 170 and 65 because birth dates were not known for one HIV-positive and two HIV-negative individuals.
2Duration of residence in Cape Town (years).
3Child = up to 15th birthday. Infection as a child was remembered by 91 HIV-positives and 26 HIV-negatives.
4Adult = after 15th birthday. Infection as an adult was remembered by 25 HIV-positives and 16 HIV-negatives.
*Mean ages when questioned were significantly different (p < 0.01).
†Mean durations of stay in Cape Town were significantly different (p < 0.01).
NSD = not significantly different.Page 4 of 8
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[38,39], from where most of the participants originated
(Table 2). The terms "flat" combined with "small",
"white" or "whitish" probably referred mainly to Taenia
segments passed in faeces. The frequency of descriptions
that fitted either Ascaris or Taenia respectively, were not
significantly different between the HIV-positive and HIV-
negative groups (Table 5). In the absence of "flat", "small"
might refer to Enterobius (1 case), or hookworm when the
colour was given as red, as after a blood meal (1 case).
Treatment used against worms and non-treatment
Recall of deworming treatment with conventional or tra-
ditional medicines, or of non-treatment, is summarised in
Table 6. Significantly more HIV-positives than HIV-nega-
tives remembered deworming treatment and fewer posi-
tives thought it was not necessary to treat against worms
(p < 0.05). These results suggest significantly more worm
infestation in the HIV-positives, both as adults and during
childhood (Table 4).
Discussion
Eighty-nine per cent of the participants were originally
from the EC, which lies geographically between the WC
and KwaZulu-Natal (KZN) provinces. In 2004, the ante-
natal HIV sero-prevalence for these three provinces was
estimated to be: WC 15.4%, EC 28.0% and KZN 40.7%
[19]. Infection by HIV, Ascaris and other helminths is
widespread in all these provinces, especially under condi-
tions of poverty in under-serviced communities [12-16].
In KZN, more species of helminths are endemic, espe-
cially in densely populated areas on the coastal plain [15].
To ensure logical development of the next phase of our
research on possible immunological interaction between
helminthiasis and HIV/AIDS, it is necessary to recognise
that worm egg excretion status is a secondary variable that
cannot be the main basis for analysis. Preliminary local
data support this point with regard to Ascaris (which
accounted for between 69% and 89% of recalls), as does
a lot of published information. In the urban environment,
the sero-prevalence of ascariasis can exceed egg-preva-
lence in children and adults. In a group of 41 women from
the same community as the study groups, 51.2% were
seropositive in terms of elevated Ascaris-specific IgE, but
only 26.3% had eggs in faeces, based on several faecal
samples from each adult [unpublished data]. In these
adults, there was no association between seropositive sta-
tus for Ascaris and the presence or absence of eggs in fae-
ces. In 600 children in the same community, Ascaris sero-
prevalence was not determined but egg-prevalence was
75% [12]. In a nearby community with better sanitation
and housing, 48% of 359 children were seropositive for
Ascaris but only 15% were egg-positive, based on two fae-
Table 5: Frequency of credible descriptions of either Ascaris worms or Taenia segments in faeces
Ascaris worms Taenia segments
Group Descriptions1 n %2 95% CI n %2 95% CI
HIV-positive 103 86 83.5 (75.1, 89.4) 17 16.5 (10.6, 24.9)
HIV-negative 42 35 83.3 (69.4, 91.7) 6 14.3 (6.2, 27.8)
CI = confidence interval.
1Descriptions of worms were given by 103 and 42 individuals in the respective groups.
2The differences between the percentages for the two groups are not significant for either Ascaris worms or Taenia segments.
Table 4: Comparison between percentages of volunteers who remembered being infected by worms
HIV-positives HIV-negatives Comparison of %
Recall of worms1 Numbers % 95% CI Numbers % 95% CI Difference 95% CI4
At any age 122/1672 73.1 65.9, 79.2 51/65 78.5 67.0, 86.7 -5.4 -16.4, 7.6
As a child 99/1672 59.3 51.7, 66.4 31/65 47.7 36.0, 59.6 11.6 -2.5, 25.3
As a child and as an adult 47/1653 28.5 22.1, 38.5 8/65 12.3 6.4, 22.5 16.2* 4.2, 25.6
As an adult (only) 70/1653 42.4 35.1, 50.1 28/65 43.1 31.8, 55.2 -0.7 -14.8, 13.0
No recall of worms 45/1672 26.9 20.8, 34.1 14/65 21.5 13.3, 33.0 5.4 -7.6, 16.4
CI = confidence interval.
1Child = up to 15th birthday. Adult = after 15th birthday.
2The reduction from n = 170 is because three individuals were uncertain about whether they had, or had not, seen worms in faeces; hence, n = 167.
3Of the 167 who gave definitive answers on infection, two knew that they had been infected as children but were not sure if they had been infected 
when adults; hence, n = 165.
4CIs which exclude zero indicate that the HIV-positives and HIV-negatives were significantly different (p < 0.05) [41].
*Significantly more HIV-positives remembered having been infected by worms as both a child and an adult (p < 0.05).Page 5 of 8
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tive were more likely to be Ascaris-seropositive. In these
examples from the urban CT environment, an immune
response to Ascaris was between two- and three-fold more
frequent in both adults and children than the presence of
eggs in faeces. In rural areas where complications such as
intestinal and duct obstructions by Ascaris are well-known
but egg-prevalence studies have not been carried out, the
position is likely to be similar.
The results make it clear that before and after sexual trans-
mission of HIV is possible, immune responses to Ascaris
antigens (as partly reflected by seropositivity), as well as to
other endemic helminths, are likely to be detectable in a
large proportion of the population studied. The presence
or absence of Ascaris eggs in faeces is of little interpreta-
tional value because infection success or failure is deter-
mined by immune responses to the antigenic challenge,
individual traits and other factors. Components of varia-
tion include the frequency of ingestion of embryonated
eggs, personal hygiene, habitual behaviour (including
geophagia [43]), anti-Ascaris immune competency or
incompetency as determined genetically [34-37], and
anergy [1,2,6-8]. Therefore, egg excretion is secondary to
genetic, environmental and other variables, especially in
adults. We contend that to evaluate potential relation-
ships between infection by Ascaris (as well as other soil-
transmitted helminths) and HIV/AIDS, research should
focus on variables that reflect anti-Ascaris immune
responses directly (such as cytokines [6-8,22,23,29-33]
and immunoglobulins [6,8,26-28]) rather than on the
presence or absence of worm eggs in excreta. When
anthelmintic treatment is evaluated experimentally in
terms of possible effects in relation to co-endemic disease,
it is important that egg-negative people be included in
deworming because they may be harbouring larval-stage
or male Ascaris worms only (that cannot produce eggs),
and/or the drug per se may have direct effects on the
immune system [25]. In terms of recommendations by
the World Health Assembly and the World Health Organ-
isation, this procedure would be ethical and safe [15,44-
47], which supports the idea of a "rapid-impact" package
for simultaneously treating several neglected tropical dis-
eases in Africa [48,49].
Recently-published research results are compatible with
our rationale [27-33]. It has been shown that individuals
who were persistently susceptible to infection by Ascaris,
as demonstrated by excretion of eggs in faeces, were char-
acterised by a weak type 2 immune response profile [30].
After age 11, a strong type 2 profile was associated with
increased resistance to infection by Ascaris [31]. A Th2
cytokine (IL-5 or the Eosinophil Differentiation Factor)
that initiates a process culminating in eosinophils attack-
ing Ascaris larvae, was significantly elevated in both egg-
positive and egg-negative residents where challenge from
Ascaris antigens is inevitable due to hyperendemicity;
compared to IL-5 levels in people living where Ascaris
challenge is unusual [33]. We therefore theorise that the
risk of HIV infection could be greater in egg-negative
adults (than in egg-positives) if a strong type 2 response
[31] down-regulates anti-viral immune factors under con-
ditions of sustained exposure to Ascaris antigens and other
pathogens in Africa [1,2]. In the same situation, progres-
sion to AIDS might sometimes be faster [9]; and the effec-
tiveness of immunisation against HIV and other diseases
may be impaired [1-5,23-25], especially when the sero-
prevalence of ascariasis (and/or other helminthic infec-
tions) is high.
In South Africa, co-infection between Ascaris (and/or
other helminths) and HIV/AIDS (and/or other non-
Table 6: Comparison between the percentages of volunteers who remembered deworming treatment or non-treatment
HIV-positives (n = 170) HIV-negatives (n = 65) Comparison
Treatment or non-treatment Numbers2 % 95% CI Numbers3 % 95% CI Difference 95% CI4
Specific deworming treatment 57/93 61.3 51.1, 70.6 20/47 42.6 29.5, 56.7 18.7* -1.3, -34.7
Mebendazole (broad spectrum) 16/93 17.2 10.9, 26.1 2/47 4.3 1.2, 14.2 12.9* 1.1, 22.4
Piperazine (narrow spectrum) 28/93 30.1 21.7, 40.1 8/47 17 8.9, 30.1 13.1 -2.5, 25.9
Traditional medicine1 13/93 14 8.4, 22.5 10/47 21.3 12.0, 34.9 -7.3 -22.0, 5.3
Treatment not deemed necessary 36/93 38.7 29.4, 48.9 27/47 57.5 43.3, 70.5 -18.7* -34.7, -1.3
CI = confidence interval.
*Significantly more HIV-positives remembered specific deworming treatment (including mebendazole) and fewer thought it was not necessary to 
treat against worms (p < 0.05).
1Traditional medicine breakdown (n = 23): aloe 11; herbs 2; pumpkin pips 2; dried worm 1; reeds 1; benzine 1; unspecified 5. Concerning the 11 
reports of the use of aloe, it has been shown that extracts of Aloe marlothii have anthelmintic activity in vitro [50].
293/170 remembered treatment detail, or non-treatment.
347/65 remembered treatment detail, or non-treatment.
4In this column, CIs that exclude zero indicate a significant difference between the percentages for the HIV-positives and HIV-negatives (p < 0.05) 
[41].Page 6 of 8
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There may be behavioural and/or sociological reasons for
the apparent association between HIV-positivity and
recall of intestinal helminthiasis reflected in our results,
but these possibilities require further investigation. Since
endemic helminthiasis will normally influence the
immune environment long before heterosexual transmis-
sion of HIV (which is mainly driving the epidemic [1,17-
19]) is possible, all aspects of potential disease interaction
need to be researched under local circumstances in prepu-
bertal children and in adults, but comparisons between
people who have or do not have helminth eggs in their
faeces must not be the primary basis for analysis. Human
genetic susceptibility and resistance to ascariasis also need
to be taken into consideration [34-37] because inevitable
confounding of research results is often ignored.
Conclusion
The groups that were studied were probably representative
of both urban and rural populations in which the epi-
demic of HIV/AIDS is a huge problem. There was a long-
term history of ascariasis (and probably other helminthic
infections) in both the HIV-positives and the HIV-nega-
tives. In women in the same community, and in children
living where housing and sanitation are better, Ascaris
sero-prevalence exceeded egg-prevalence by two- and
three-fold, respectively. For ongoing and future analyses
of possible consequences of co-infection by Ascaris (and/
or other helminths) and HIV/AIDS (and/or other
bystander conditions), comparisons must be based
mainly on disease-related immunological variables. Espe-
cially in adults, comparisons cannot be based only on the
presence or absence of eggs in excreta.
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